Class information for:
Level 1: HEIDELBERG CAPSULE//ROXATIDINE ACETATE//SECT PEDIAT CLIN PHARMACOL TOXICOL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
9060 1124 28.3 52%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
810 11347 HISTAMINE H 3 RECEPTOR//THIOPERAMIDE//HISTAMINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 HEIDELBERG CAPSULE Author keyword 1 40% 0% 2
2 ROXATIDINE ACETATE Author keyword 1 40% 0% 2
3 SECT PEDIAT CLIN PHARMACOL TOXICOL Address 1 33% 0% 2
4 ROXATIDINE Author keyword 1 14% 0% 5
5 BUFURALOL 1 HYDROXYLASE Author keyword 1 50% 0% 1
6 CAS 78273 80 0 Author keyword 1 50% 0% 1
7 CRIT CARECHILDRENS HOSP MICHIGAN Address 1 50% 0% 1
8 ETHYL BISCOUMACETATE Author keyword 1 50% 0% 1
9 HISTAMINE CIMETIDINE Author keyword 1 50% 0% 1
10 HISTAMINE 2 RECEPTOR BLOCKERS Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 HEIDELBERG CAPSULE 1 40% 0% 2 Search HEIDELBERG+CAPSULE Search HEIDELBERG+CAPSULE
2 ROXATIDINE ACETATE 1 40% 0% 2 Search ROXATIDINE+ACETATE Search ROXATIDINE+ACETATE
3 ROXATIDINE 1 14% 0% 5 Search ROXATIDINE Search ROXATIDINE
4 BUFURALOL 1 HYDROXYLASE 1 50% 0% 1 Search BUFURALOL+1+HYDROXYLASE Search BUFURALOL+1+HYDROXYLASE
5 CAS 78273 80 0 1 50% 0% 1 Search CAS+78273+80+0 Search CAS+78273+80+0
6 ETHYL BISCOUMACETATE 1 50% 0% 1 Search ETHYL+BISCOUMACETATE Search ETHYL+BISCOUMACETATE
7 HISTAMINE CIMETIDINE 1 50% 0% 1 Search HISTAMINE++CIMETIDINE Search HISTAMINE++CIMETIDINE
8 HISTAMINE 2 RECEPTOR BLOCKERS 1 50% 0% 1 Search HISTAMINE+2+RECEPTOR+BLOCKERS Search HISTAMINE+2+RECEPTOR+BLOCKERS
9 P 450 INDUCTION 1 50% 0% 1 Search P+450+INDUCTION Search P+450+INDUCTION
10 P 450 INHIBITION 1 50% 0% 1 Search P+450+INHIBITION Search P+450+INHIBITION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 TZU 0460 6 100% 0% 4
2 MENTAL CONFUSION 5 43% 1% 9
3 NERVOUS SYSTEM REACTIONS 3 38% 1% 6
4 CSF CONCENTRATIONS 3 60% 0% 3
5 OUTPATIENT SURVEILLANCE PROGRAM 2 43% 0% 3
6 H 2 RECEPTOR ANTAGONISTS CIMETIDINE 1 100% 0% 2
7 HYDROCHLORIDE TZU 0460 1 50% 0% 2
8 INDUCED MENTAL CONFUSION 1 100% 0% 2
9 RANITIDINE ASSOCIATED DELIRIUM 1 100% 0% 2
10 RANITIDINE BIOAVAILABILITY 1 100% 0% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
DRUG-THERAPY - HISTAMINE2-RECEPTOR ANTAGONISTS - STANDARD THERAPY FOR ACID-PEPTIC DISEASE .1. 1990 181 151 70%
PHARMACOKINETIC INTERACTIONS OF CIMETIDINE 1987 1987 183 179 76%
RANITIDINE VERSUS CIMETIDINE - A COMPARISON OF THEIR POTENTIAL TO CAUSE CLINICALLY IMPORTANT DRUG-INTERACTIONS 1988 65 82 83%
PHARMACOKINETICS AND PHARMACODYNAMICS OF H-2-RECEPTOR ANTAGONISTS IN PATIENTS WITH RENAL-INSUFFICIENCY 1993 18 53 74%
Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence 2005 10 49 61%
PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF HISTAMINE H-2-RECEPTOR ANTAGONISTS - RELATIONSHIP BETWEEN INTRINSIC POTENCY AND EFFECTIVE PLASMA-CONCENTRATIONS 1991 69 62 60%
FAMOTIDINE AND THEOPHYLLINE PHARMACOKINETICS - AN UNEXPECTED CIMETIDINE-LIKE INTERACTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 1993 14 8 75%
The tolerability and safety profile of famotidine 1996 28 27 48%
EFFECTS OF ANTACIDS ON THE CLINICAL PHARMACOKINETICS OF DRUGS - AN UPDATE 1990 59 21 52%
CENTRAL-NERVOUS-SYSTEM REACTIONS TO HISTAMINE-2 RECEPTOR BLOCKERS 1991 78 47 40%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 SECT PEDIAT CLIN PHARMACOL TOXICOL 1 33% 0.2% 2
2 CRIT CARECHILDRENS HOSP MICHIGAN 1 50% 0.1% 1
3 LEVENT 4 1 50% 0.1% 1
4 NEUROL DEJERINE 1 50% 0.1% 1
5 DEKAM IKU 0 33% 0.1% 1
6 MED BIOL PHARM 0 33% 0.1% 1
7 REG PHARMACOVIGILANCE BASSE NORMANDIE 0 33% 0.1% 1
8 MED INFORMAT PROC STAT 0 25% 0.1% 1
9 SECT CLIN PHARMACOL EXPT THER EUT 0 20% 0.1% 1
10 GESELL PHARMAKOKINET 0 10% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000260645 FAMOTIDINE//RANITIDINE HYDROCHLORIDE//NIZATIDINE
2 0.0000217142 HVIDOVRE HOSP ENDOCRINOL//E170//MALE SEXUAL HLTH
3 0.0000184851 SUCRALFATE//PEPTIC ULCER THERAPY//DE NOL
4 0.0000183325 INO 2628 CZ//DOUBLE PEAKS//DISCONTINUOUS ABSORPTION
5 0.0000160730 CAS 76963 41 2//MIFENTIDINE//HISTAMINE H 2 RECEPTORS
6 0.0000139919 TRIMETHADIONE//ZAKLAD CHEM FIZJOL//ZAKLAD CHEM FIZJOLOGICZNEJ
7 0.0000075252 SPATIAL VELOCITY ELECTROCARDIOGRAM//BISOPROLOL EFFICACY//INTRAVESICAL BCG INSTILLATION
8 0.0000075190 CAS 58 55 9//ABT BIOPHARM PHARMAKOKINETIK//BRONCHORETARD R
9 0.0000073075 STRESS ULCER PROPHYLAXIS//STRESS ULCER//STRESS ULCERATION
10 0.0000072187 K M AND V MAX//PERFUSED MOUSE LIVER//N DESMETHYLDIAZEPAM